Tomasz Sewastianik

Tomasz Sewastianik's work experience includes being a Senior Scientist and Translational Medicine Leader at Affini-T Therapeutics since November 2021. Prior to this, they worked at the Dana-Farber Cancer Institute starting in October 2015. At Dana-Farber, they held the positions of Instructor from March 2020 to December 2021 and Research Fellow from October 2015 to February 2020.

Tomasz Sewastianik has a Bachelor's degree in Biotechnology from Uniwersytet Marii Curie-Skłodowskiej w Lublinie, which they earned from 2006 to 2009. Tomasz then pursued a Master's degree in Biotechnology from the same university, from 2009 to 2011. In 2011, they enrolled at the Institute of Hematology and Transfusion Medicine in Warsaw, Poland, where they obtained a Doctor of Philosophy (PhD) in Medicine from 2011 to 2015. During their doctoral studies, they also conducted research at the Maria Sklodowska-Curie Memorial Cancer Center-Institute of Oncology in Warsaw, Poland, earning a second Doctor of Philosophy (PhD) degree in Medicine from 2014 to 2015. Overall, Tomasz Sewastianik has a strong educational background in Biotechnology and Medicine.